"melanoma patients" trang 3 - tải miễn phí từ tailieunhanh
Báo cáo hóa học:

Báo cáo hóa học: " Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100derived epitope peptide "
12    51    0
Báo cáo hóa học:

Báo cáo hóa học: "Evaluation of six CTLA-4 polymorphisms in highrisk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial"
9    35    0
báo cáo hóa học:

báo cáo hóa học:" Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma"
11    45    0
Báo cáo sinh học:

Báo cáo sinh học: "Interferon signaling patterns in peripheral blood lymphocytes may predict clinical outcome after high-dose interferon therapy in melanoma patients"
9    47    0
Báo cáo sinh học:

Báo cáo sinh học: "Methylation levels of the “long interspersed nucleotide element-1” repetitive sequences predict survival of melanoma patients"
10    34    0
báo cáo hóa học:

báo cáo hóa học:" Interferon signaling patterns in peripheral blood lymphocytes may predict clinical outcome after high-dose interferon therapy in melanoma patients"
9    44    0
báo cáo hóa học:

báo cáo hóa học:" Methylation levels of the “long interspersed nucleotide element-1” repetitive sequences predict survival of melanoma patients"
10    34    0
Germline and somatic mutations in patients with multiple primary melanomas: A next generation sequencing study

Germline and somatic mutations in patients with multiple primary melanomas: A next generation sequencing study
10    100    0
Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: Potential role of Th1-dominant immune response in immune-related adverse events: Two case reports

Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: Potential role of Th1-dominant immune response in immune-related adverse events: Two case reports
7    55    0
Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2

Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2
5    38    1
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients

Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
8    48    1
Effect of genetic ancestry on leukocyte global DNA methylation in cancer patients

Effect of genetic ancestry on leukocyte global DNA methylation in cancer patients
8    55    1
DW-MRI in assessment of the hypoxic fraction, interstitial fluid pressure, and metastatic propensity of melanoma xenografts

DW-MRI in assessment of the hypoxic fraction, interstitial fluid pressure, and metastatic propensity of melanoma xenografts
9    49    1
Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations

Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations
13    55    1
Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis

Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis
4    40    1
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: The multicentre prospective Safe Stop trial

Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: The multicentre prospective Safe Stop trial
9    42    1
Gene expression and immune infiltration in melanoma patients with different mutation burden

Gene expression and immune infiltration in melanoma patients with different mutation burden
12    25    1
Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases

Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases
11    21    1
Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: A single-arm, multicenter, phase II study

Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: A single-arm, multicenter, phase II study
11    4    1
Introduction of a pilot program to measure and improve the clinical care of melanoma patients in the Lower Silesian Voivodeship in Poland: A report of 20 months experience

Introduction of a pilot program to measure and improve the clinical care of melanoma patients in the Lower Silesian Voivodeship in Poland: A report of 20 months experience
13    8    1